On March 24, CTSW hosted a mock investor pitch workshop with attendees of the Pepper NYC healthtech founder community and guest judge Vance Dekker Vargas of Techstars. Three healthtech founders delivered their investor pitches, and Vance and the room of founders discussed strengths and tips for each pitch and investor pitches generally. This is the […]
CTSW is pleased to have represented Ocuvex Therapeutics, Inc., a biopharmaceutical company specializing in ophthalmic therapeutics, in its Merger Agreement with Onconetix, Inc. (Nasdaq: ONCO). Under the Merger Agreement, Onconetix will acquire all Ocuvex equity interests in exchange for newly-issued Onconetix shares, resulting in Ocuvex equity holders owning 90% of the combined company, subject to […]